6-STEPPs: A Modular Tool to Facilitate Clinician Participation in Fair Decisions for Funding New Cancer Drugs

To design a tool to assist clinician participation with cancer drug funding decisions. Public policy-makers and insurers are struggling with funding decisions regarding increasingly expensive new cancer drugs. Increasingly, oncologists are contributing to the process of review that leads to such decisions. We were asked to design a system for ranking new cancer drugs for priority-based funding decisions.
Oncology, Cancer Drugs
Sinclair, Shane, and George P. Browman, et al. (2008). 6-STEPPs: A modular tool to facilitate clinician participation in fair decisions for funding new cancer drugs, Journal of Oncology Practice. Vol. 4. Issue 1.